Preclinical studies on mantle cell lymphoma (MCL) and Waldenström macroglobulinemia (WM) also indicate that G-1-mediated selective GPER1 activation exerts anti-tumor activity through ROS production, NF-κB inhibition [21], or p53 upregulation [22]. The gene discussed is TP53; the disease is mantle cell lymphoma.